-transparent.png){kind=logo}
Twenty-four healthy adult male volunteers were randomly assigned to one of two rimantadine regimens. The 12 volunteers assigned to regimen 1 orally received a single 100-mg rimantadine tablet followed 5 days later by 100 mg of rimantadine twice a day for 10 days. Volunteers assigned to regimen 2 ingested a single 100-mg rimantadine tablet followed 5 days later by 100 mg once a day for 10 days. The results of the study suggest that the pharmacokinetics of rimantadine are linear and accumulation of the drug during repetitive multiple doses is predictable.
Related Publications
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
April 1976,
Clinical pharmacology and therapeutics,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
September 2001,
Antimicrobial agents and chemotherapy,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
January 1986,
International journal of clinical pharmacology research,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
January 1987,
Arzneimittel-Forschung,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
January 1997,
Pharmacotherapy,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
January 1991,
European journal of drug metabolism and pharmacokinetics,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
January 1991,
European journal of drug metabolism and pharmacokinetics,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
July 1992,
Journal of clinical pharmacology,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
January 2005,
Antimicrobial agents and chemotherapy,
R J Wills, and
D A Farolino, and
N Choma, and
N Keigher
December 1977,
European journal of clinical pharmacology,
